Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Nandakumar Packiriswamy

2PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jun 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumors.

|Apr 25, 2020
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma.

Nandakumar Packiriswamy, Deepak Upreti, Yumei Zhou

Pageof 1

Frequent Collaborators

1 joint publications

Jaime R Merchan

1 joint publications

Manish R Patel

1 joint publications

Timothy P Cripe

1 joint publications

Matthew O Old

1 joint publications

Jen Boughton

1 joint publications

Rosa M Diaz

1 joint publications

Kah-Whye Peng

1 joint publications

Stephen J Russell

1 joint publications

Luke Russell

1 joint publications

Erol Wiegert

Frequent Collaborators

1 joint publications

Jaime R Merchan

1 joint publications

Manish R Patel

1 joint publications

Timothy P Cripe

1 joint publications

Matthew O Old